GENASYS INC.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $40.8M | $24.0M | $46.7M | $54.0M | $47.0M | $43.0M | $37.0M | $26.3M |
| Cost of Revenue | $23.8M | $13.8M | $24.9M | $26.8M | $23.6M | $20.4M | $18.5M | $13.6M |
| Gross Profit | $17.0M | $10.2M | $21.8M | $27.3M | $23.4M | $22.6M | $18.5M | $12.7M |
| Gross Margin | 41.6% | 42.4% | 46.6% | 50.5% | 49.8% | 52.6% | 49.9% | 48.4% |
| Operating Expenses | ||||||||
| Research & Development | $8.1M | $9.6M | $8.1M | $7.0M | $4.9M | $4.6M | $4.5M | $3.5M |
| SG&A Expense | $25.7M | $27.3M | $24.6M | $22.6M | $17.4M | $12.0M | $10.8M | $10.7M |
| Operating Income | $-16.8M | $-26.7M | $-11.0M | $-15.5M | $1.1M | $6.0M | $3.1M | $-1.5M |
| Operating Margin | -41.2% | -111.3% | -23.5% | -28.7% | 2.3% | 14.0% | 8.5% | -5.6% |
| Interest Expense | — | — | — | — | — | — | — | $20.9K |
| Pretax Income | $-18.0M | $-32.1M | $-11.0M | $-15.5M | $1.1M | $6.2M | $3.4M | $-1.4M |
| Income Tax Expense | $119.0K | $-405.0K | $7.4M | $741.0K | $434.0K | $-5.7M | $572.0K | $2.4M |
| Net Income | $-18.1M | $-31.7M | $-18.4M | $-16.2M | $704.0K | $11.9M | $2.8M | $-3.7M |
| Net Margin | -44.4% | -132.2% | -39.4% | -30.0% | 1.5% | 27.6% | 7.5% | -14.2% |
| EPS (Basic) | $-0.40 | $-0.72 | $-0.50 | $-0.44 | $0.02 | $0.36 | $0.09 | $-0.12 |
| EPS (Diluted) | $-0.40 | $-0.72 | $-0.50 | $-0.44 | $0.02 | $0.35 | $0.08 | $-0.12 |
| Shares Outstanding (Basic) | 45.1M | 44.3M | 36.9M | 36.5M | 34.4M | 33.2M | 32.7M | 32.5M |
| Shares Outstanding (Diluted) | 45.1M | 44.3M | 36.9M | 36.5M | 35.6M | 34.1M | 33.4M | 32.5M |
| Dividends Per Share | $0.00 | $0.00 | $0.00 | — | — | — | — | — |